Seeing Is Believing
with an average price target of $38.84. This is a potential upside of $30.18 (348.5%) from yesterday's end of day stock price of $8.66.
MoonLake Immunotherapeutics's activity chart (see below) currently has 28 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 54.89 days.
Highest price target for MLTX is $82, Lowest price target is $66, average price target is $74.
Most recent stock forecast was given by RICHARD LAW from GOLDMAN SACHS on 06-Aug-2025. First documented stock forecast 21-Jul-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$82
$20.01 (32.28%)
$73
2 months ago
(06-Aug-2025)
0/4 (0%)
$29.24 (55.42%)
Buy
$66
$4.01 (6.47%)
$66
4 months 23 days ago
(13-May-2025)
0/13 (0%)
$27.46 (71.25%)
Buy
$104
$42.01 (67.77%)
$92
1 years 3 months 11 days ago
(25-Jun-2024)
1/12 (8.33%)
$64.3 (161.96%)
96
Buy
$100
$91.57 (1086.24%)
$30
1 years 6 months 25 days ago
(11-Mar-2024)
2/3 (66.67%)
$52.95 (112.54%)
180
Buy
$69
$7.01 (11.31%)
$74
1 years 9 months 18 days ago
(18-Dec-2023)
0/2 (0%)
$9.42 (15.81%)
What is MLTX (MoonLake Immunotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?
Which analyst has the current lower performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?
Which analyst has the most public recommendations on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most bullish on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most reserved on MLTX (MoonLake Immunotherapeutics)?